uniQure faces securities fraud lawsuit over FDA approval delay

March 17, 2026 10:39 PM

Law firm Kahn Swick & Foti has filed a securities fraud class action lawsuit against uniQure N.V. (NASDAQ: QURE) in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found